• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒介导基因治疗感染预防与控制方法的全面文献综述。

A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies.

作者信息

Blind Jill E, Ghosh Sumit, Niese Taylor D, Gardner Julia C, Stack-Simone Stephanie, Dean Abigail, Washam Matthew

机构信息

Department of Pharmacy, Nationwide Children's Hospital, Columbus, OH, USA.

Department of Research Safety, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

出版信息

Antimicrob Steward Healthc Epidemiol. 2024 Jan 31;4(1):e15. doi: 10.1017/ash.2024.1. eCollection 2024.

DOI:10.1017/ash.2024.1
PMID:38415097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10897728/
Abstract

OBJECTIVE

This comprehensive literature scoping review outlines available infection prevention and control (IPC) methods for viral-mediated gene therapies and provides one IPC strategy for the healthcare setting based on a single-center recommendation.

METHODS

A team of experts in pharmacy, healthcare epidemiology, and biosafety with experience in viral-mediated gene therapy was assembled within a pediatric hospital to conduct a comprehensive literature scoping review. The comprehensive review included abstracts and full-text articles published since 2009 and utilized prespecified search terms of the five viral vectors of interest: adenovirus (AV), retrovirus (RV), adeno-associated virus (AAV), lentivirus (LV), and herpes simplex virus (HSV). Case reports, randomized controlled trials, and bench research studies were all included, while systematic reviews were excluded.

RESULTS

A total of 4473 case reports, randomized control trials, and benchtop research studies were identified using the defined search criteria. Chlorine compounds were found to inactivate AAV and AV, while alcohol-based disinfectants were ineffective. There was a relative paucity of studies investigating surface-based disinfection for HSV, however, alcohol-based disinfectants were effective in one study. Ultraviolent irradiation was also found to inactivate HSV in numerous studies. No studies investigated disinfection for LV and RV vectors.

CONCLUSIONS

The need to define IPC methods is high due to the rapid emergence of viral-mediated gene therapies to treat rare diseases, but published clinical guidance remains scarce. In the absence of these data, our center recommends a 1:10 sodium hypochlorite solution in clinical and academic environments to ensure complete germicidal activity of viral-mediated gene therapies.

摘要

目的

本综合性文献范围综述概述了病毒介导基因治疗可用的感染预防与控制(IPC)方法,并基于单中心建议为医疗机构提供了一种IPC策略。

方法

一家儿童医院组建了一个由在病毒介导基因治疗方面有经验的药学、医疗保健流行病学和生物安全专家组成的团队,进行综合性文献范围综述。该综合性综述包括自2009年以来发表的摘要和全文文章,并使用了预先指定的有关五种感兴趣的病毒载体的检索词:腺病毒(AV)、逆转录病毒(RV)、腺相关病毒(AAV)、慢病毒(LV)和单纯疱疹病毒(HSV)。纳入了病例报告、随机对照试验和实验室研究,排除了系统评价。

结果

使用既定检索标准共识别出4473篇病例报告、随机对照试验和实验室研究。发现氯化合物可使AAV和AV失活,而酒精类消毒剂无效。关于HSV基于表面消毒的研究相对较少,不过在一项研究中酒精类消毒剂是有效的。在众多研究中还发现紫外线照射可使HSV失活。没有研究调查LV和RV载体的消毒情况。

结论

由于用于治疗罕见病的病毒介导基因治疗迅速涌现,因此对定义IPC方法的需求很高,但已发表的临床指南仍然稀缺。在缺乏这些数据的情况下,我们中心建议在临床和学术环境中使用1:10的次氯酸钠溶液,以确保病毒介导基因治疗具有完全的杀菌活性。

相似文献

1
A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies.病毒介导基因治疗感染预防与控制方法的全面文献综述。
Antimicrob Steward Healthc Epidemiol. 2024 Jan 31;4(1):e15. doi: 10.1017/ash.2024.1. eCollection 2024.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.改善物质使用障碍康复期学生行为和学业成果的康复学校:一项系统综述
Campbell Syst Rev. 2018 Oct 4;14(1):1-86. doi: 10.4073/csr.2018.9. eCollection 2018.
4
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
5
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
6
Disinfection of Tonometers: A Report by the American Academy of Ophthalmology.眼压计的消毒:美国眼科学会报告。
Ophthalmology. 2017 Dec;124(12):1867-1875. doi: 10.1016/j.ophtha.2017.05.033. Epub 2017 Jul 11.
7
Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.医护人员遵守呼吸道传染病感染预防与控制(IPC)指南的障碍与促进因素:一项快速定性证据综合分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD013582. doi: 10.1002/14651858.CD013582.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
Environmental cleaning to prevent COVID-19 infection. A rapid systematic review.通过环境清洁预防新型冠状病毒肺炎感染。一项快速系统评价。
Sao Paulo Med J. 2020 Nov-Dec;138(6):505-514. doi: 10.1590/1516-3180.2020.0417.09092020.
10
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.针对正在接受癌症治疗患者的单纯疱疹病毒预防和治疗干预措施。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006706. doi: 10.1002/14651858.CD006706.pub2.

本文引用的文献

1
Food and Drug Administration Guidance on Design of Clinical Trials for Gene Therapy Products with Potential for Genome Integration or Genome Editing and Associated Long-Term Follow-Up of Research Subjects.美国食品药品监督管理局关于具有基因组整合或基因组编辑潜力的基因治疗产品临床试验设计及研究对象相关长期随访的指南。
Appl Biosaf. 2022 Dec 1;27(4):201-209. doi: 10.1089/apb.2022.0022. Epub 2022 Nov 23.
2
FDA Guidance on Shedding and Environmental Impact in Clinical Trials Involving Gene Therapy Products.美国食品药品监督管理局关于涉及基因治疗产品的临床试验中脱落和环境影响的指南。
Appl Biosaf. 2022 Sep 1;27(3):191-197. doi: 10.1089/apb.2022.0020. Epub 2022 Sep 14.
3
A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges.基因治疗研究中的变化世界:医学进步的激动人心机遇与生物安全挑战。
Appl Biosaf. 2021 Dec 1;26(4):179-192. doi: 10.1089/apb.2021.0020. Epub 2021 Nov 24.
4
Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.用于基因治疗的病毒载体系统:进展与生物安全挑战的综合文献综述
Appl Biosaf. 2020 Mar 1;25(1):7-18. doi: 10.1177/1535676019899502.
5
The United States' Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research.美国的监管环境正在不断演变,以适应即将到来的基因治疗研究热潮。
Appl Biosaf. 2019 Sep 1;24(3):147-152. doi: 10.1177/1535676019854866.
6
Virucidal activities of novel hand hygiene and surface disinfectant formulations containing EGCG-palmitates (EC16).新型手部卫生和表面消毒剂配方中 EGCG-棕榈酸酯(EC16)的病毒杀灭活性。
Am J Infect Control. 2022 Nov;50(11):1212-1219. doi: 10.1016/j.ajic.2022.05.027. Epub 2022 Jun 4.
7
Biosafety Considerations for Viral Vector Gene Therapy: An Explanation and Guide for the Average Everyday-Hero Pharmacist.病毒载体基因治疗的生物安全考量:给普通药师的解释与指南
J Pharm Pract. 2023 Dec;36(6):1532-1539. doi: 10.1177/08971900221104250. Epub 2022 May 18.
8
Viral vector platforms within the gene therapy landscape.病毒载体平台在基因治疗领域中的应用。
Signal Transduct Target Ther. 2021 Feb 8;6(1):53. doi: 10.1038/s41392-021-00487-6.
9
Inactivation of Adeno-Associated Viral Vectors by Oxidant-Based Disinfectants.基于氧化剂的消毒剂对腺相关病毒载体的灭活作用。
Hum Gene Ther. 2021 Jul;32(13-14):771-781. doi: 10.1089/hum.2020.120. Epub 2020 Nov 6.
10
Viral-mediated gene therapy and genetically modified therapeutics: A primer on biosafety handling for the health-system pharmacist.病毒介导的基因治疗和基因修饰治疗:医疗系统药剂师生物安全处理指南。
Am J Health Syst Pharm. 2019 May 17;76(11):795-802. doi: 10.1093/ajhp/zxz056.